A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, a suspension HEK293 cell-based AAV production protocol is presented, resulting in reduced time and labor needed for vector production using components that are available for research purposes from commercial vendors.
Adeno-associated viral vectors (AAVs) are a remarkable tool for investigating the central nervous system (CNS). Innovative capsids, such as AAV.PHP.eB, demonstrate extensive transduction of the CNS by intravenous injection in mice. To achieve comparable transduction, a 100-fold higher titer (minimally 1 x 1011 genome copies/mouse) is needed compared to direct injection in the CNS parenchyma. In our group, AAV production, including AAV.PHP.eB relies on adherent HEK293T cells and the triple transfection method. Achieving high yields of AAV with adherent cells entails a labor- and material-intensive process. This constraint prompted the development of a protocol for suspension-based cell culture in conical tubes. AAVs generated in adherent cells were compared to the suspension production method. Culture in suspension using transfection reagents Polyethylenimine or TransIt were compared. AAV vectors were purified by iodixanol gradient ultracentrifugation followed by buffer exchange and concentration using a centrifugal filter. With the adherent method, we achieved an average of 2.6 x 1012 genome copies (GC) total, whereas the suspension method and Polyethylenimine yielded 7.7 x 1012 GC in total, and TransIt yielded 2.4 x 1013 GC in total. There is no difference in in vivo transduction efficiency between vectors produced with adherent compared to the suspension cell system. In summary, a suspension HEK293 cell based AAV production protocol is introduced, resulting in a reduced amount of time and labor needed for vector production while achieving 3 to 9 times higher yields using components available from commercial vendors for research purposes.
Adeno-associated virus (AAV) was discovered in 1965 and has since been used in a myriad of applications1. AAVs have been applied in neuroscience research to study gene and neuronal function, map neurocircuits, or produce animal models for disease2. Traditionally, this is done by injecting directly at the site of interest, as most natural serotypes do not cross the blood-brain barrier or need a high dose to do so1,2,3.
With the discovery of AAV.PHP.B4 and next-generation capsids....
All experimental procedures were approved by the institutional animal care and use committee of the Royal Netherlands Academy of Sciences (KNAW) and were in accordance with the Dutch Law on Animal Experimentation under project number AVD8010020199126. In Figure 1, a schematic overview of the complete protocol is provided. From seeding cells to AAV purification, the protocol takes 6 days to complete.
1. Reagent preparation
Most academic labs use adherent HEK293T cells for AAV production8,9. While this works relatively well when small amounts of AAV are needed for direct injection, a 100-fold higher titer (minimally 1 x 1011 GC/mouse) is needed to achieve similar transduction with systemic capsids such as AAV.PHP.eB.
In this protocol, the production of AAV using suspension HEK293 cells cultured in conical tubes was established. Small-scale cult.......
Systemic administration of AAV is a powerful tool for gene transfer to the CNS; however, the production of AAV is an expensive and laborious process. By using suspension cells, labor and plastics are reduced compared to the adherent culture of HEK293T on 15 cm2 plates. Furthermore, the conical tubes implemented here are easy to handle and maximize the use of laboratory space. The protocol was set up by two researchers and subsequently applied by others in the lab. A series of productions by three independ.......
This work was supported by a grant from the Royal Netherlands Academy of Arts and Sciences (KNAW) research fund and a grant from Start2Cure (0-TI-01). We thank Leisha Kopp for her input and advice in the setup of the protocol. Figures were created using Biorender.
....Name | Company | Catalog Number | Comments |
39 mL, Quick-Seal Round-Top Polypropylene Tube, 25 x 89 mm - 50Pk | Beckman Coulter | 342414 | |
Adapter 600 mL conical tubes, for rotor S-4x1000, | eppendorf | 5920701002 | |
Adapter Plate fits 16 bioreactors of 600 ml | Infors HT/ TPP | 587633 | |
Aerosol-tight caps, for 750 mL round buckets | eppendorf | 5820747005 | |
Centrifuge 5920 R G, 230 V, 50-60 Hz, incl. rotor S-4x1000, round buckets and adapter 15 mL/50 mL conical tubes | eppendorf | 5948000315 | |
Distilled Water | Gibco | 15230147 | |
DNase I recombinant, RNase-free | Roche | 4716728001 | |
DNase I recombinant, RNase-free | Roche | 4716728001 | |
DPBS, calcium, magnesium | Gibco | 14040091 | |
DPBS, no calcium, no magnesium | Gibco | 14190144 | |
Fisherbrand Disposable PES Filter Units 0,2 | Fisher | FB12566504 | |
Fisherbrand Disposable PES Filter Units 0,45 | Fisher | FB12566505 | |
Holder for 50 ml culture tubes also fits falcon tube | Infors HT/ TPP | 31362 | |
Holder for 600 ml cell culture tube | Infors HT/ TPP | 66129 | |
Incubator Minitron 50 mm | Infors HT | 500043 | |
LV-MAX Production Medium | Gibco | A3583401 | |
N-Tray Universal | Infors HT/ TPP | 31321 | |
OptiPrep - Iodixanol | Serumwerk bernburg | 1893 | |
PEI MAX - Transfection Grade Linear Polyethylenimine Hydrochloride (MW 40,000) | Poly-sciences | 24765-100 | |
Phenol red solution | Sigma-Aldrich | 72420100 | |
Poly(ethylene glycol) 8000 | Sigma-Aldrich | 89510 | |
TransIT-VirusGEN | Mirus | Mir 6706 | |
Trypan Blue Solution, 0.4% | Gibco | 5250061 | |
TubeSpin Bioreactors-50ml | TTP | 87050 | |
TubeSpin Bioreactors-600ml | TTP | 87600 | |
Viral Production Cells | Gibco | A35347 | |
Vivaspin 20 MWCO 100 000 | Cytvia | 28932363 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved